Scroll To Top

FDA approves
generic AZT for U.S. sale

FDA approves
generic AZT for U.S. sale

Approval allows first foreign-made generic anti-HIV drug in U.S. market.

The Food and Drug Administration on Friday granted approval to a generic version of AZT made by Indian drugmaker Aurobindo Pharma for sale in the United States. The approval marks the first time a generic anti-HIV medication made by a foreign firm has been approved for U.S. sale. The U.S. patent on AZT, sold under the brand name Retrovir, expired in September. Aurobindo Pharma's cheaper version of the medication is expected to be available in the U.S. later this month. (The Advocate)

Advocate Magazine - KehlaniAdvocate Channel Promotion

From our Sponsors

Most Popular

Be sure to follow Advocate on your favorite social platforms!


Want more news, top stories, and videos? Check out the all NEW Advocate Channel!
Your 24/7 streaming source for equality news and lifestyle trends.
Click this link right now:

Latest Stories